Perhaps you've not been following OCC that long.
Everyone on here (rightly) criticized the company for its poor communication n the past. The company now puts these up as a courtesy, at my behest years ago. Its a practice more companies should follow, looking after retail investors as well as Insto's.
Would you rather not be privy to information on the company's progression, that Insto's are?
Bio-tech coverage from analysts in Australia is awful. I put up a brief Shaw's video on OCC before. The guy was utterly clueless getting ATI and CelGro Tendon mixed up. OCC management are trying to encourage better understanding, coverage and Institutional interest is all, which I applaud as a shareholder.
Ann: Investor Presentation, page-11
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.31M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $65.26K | 181.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 56760 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.04pm 28/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |